Clinical studies have reported minimal side effects, which may include: Mild irritation at the injection site
The safety profile remains excellent with minimal side effects across decades of use
96401/96402 for Chemotherapy and Hormonal Agents The most critical code-selection rule for procedure code 96372 is confirming that the drug administered is not a chemotherapy or hormonal antineoplastic agent: Non-hormonal chemotherapy agents (e.g., methotrexate for cancer, bleomycin) administered SC or IM CPT 96401 , not 96372 CPT code Hormonal antineoplastic agents (e.g., leuprolide acetate/Lupron, goserelin/Zoladex, degarelix) administered SC or IM CPT 96402 , not procedure code 96372 Note that methotrexate administered for rheumatoid arthritis or psoriasis (not cancer) may be reported under CPT code 96372 since it is used in that context as an immunosuppressant rather than a chemotherapy agent
Seventy-five women were assessed, and a subgroup with reduced urinary excretion of the melatonin metabolite 6-sulfatoxymelatonin was divided between AEDG and placebo exposure for 20 days
Like earlier versions, theyre expected to be most protective against COVID-19s worst consequences rather than mild infection
Zhao, B., Fisher, B
